State Street Corp Vir Biotechnology, Inc. Transaction History
State Street Corp
- $2.47 Trillion
- Q4 2024
A detailed history of State Street Corp transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, State Street Corp holds 5,074,731 shares of VIR stock, worth $37.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,074,731
Previous 5,625,533
9.79%
Holding current value
$37.4 Million
Previous $42.1 Million
11.6%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding VIR
# of Institutions
232Shares Held
90.1MCall Options Held
1.28MPut Options Held
235K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$123 Million1.08% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$121 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$96.8 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.22MShares$23.7 Million0.64% of portfolio
-
Geode Capital Management, LLC Boston, MA2.2MShares$16.2 Million0.0% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $978M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...